ALX Oncology

‌

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.

Industries

Biotechnology

Headquarters

Burlingame, United States

Employees

11-50

Links

Org chart

Athanasios Tsiatis

SVP, Clinical Development

Yeong-Liang Lin

SVP, Drug Safety & Pharmacovigilance

Hank Stern

VP, Chemistry, Manufacturing & Controls

Susan Vermeir

VP, Regulatory Affairs & Quality

Hadi Falahatpisheh

VP, Preclinical Development

Marija Vrljic

VP, Antibody Technologies

Jeanne Jew

Chief Business Officer

Linda Woo

Senior Director Of Clinical Operations

Lisa Sauer

Senior Vice President, Regulatory Affairs And Quality Assurance

Board & advisors

Corey Goodman

Executive Chairman, Board of Directors

Board Member

CEO

Board Member

Chairman, Scientific Advisory Board

Charles M. Baum

Advisor

Kipp Weiskopf

Advisor

Scott Garland

Director

Teams

Clinical Development and Operations

5 people · 0 jobs

Leadership Team

6 people · 0 jobs

Regulatory Affairs and Compliance

5 people · 0 jobs

Offices

HQ
10 people · 0 jobs
DO
+6

Similar companies

Tango Therapeutics

3 followers

Cellares

4 followers

Gilead Sciences

161 followers

Regeneron

132 followers

Illumina

79 followers

Agilent Technologies

82 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

45 followers

GRAIL

29 followers

Cytiva

16 followers

PerkinElmer

12 followers

Explore companies